Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
Blue curve MMWR spacer

Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: Type 508 Accommodation and the title of the report in the subject line of e-mail.

Update: Influenza Activity --- United States, March 5--11, 2006

During March 5--11, 2006,* the number of states reporting widespread influenza activity remained at 25. Sixteen states reported regional activity, three reported local activity, and six reported sporadic activity (Figure 1).§

The percentage of specimens testing positive for influenza increased in the United States overall. During the preceding 3 weeks (weeks 8--10), the percentage of specimens testing positive for influenza ranged from 36.8% in the East North Central region to 11.1% in the Pacific region. During this period, 52.6% of isolates from the Mountain region have been influenza B. The influenza B isolates reported from this region accounted for 41.1% of the B isolates reported during this time period. Other regions reporting more than 30.0% of recent isolates as influenza B include the West North Central and West South Central regions. The percentage of outpatient visits for influenza-like illness (ILI) during the week ending March 11 remains above the national baseline.** The percentage of deaths attributed to pneumonia and influenza (P&I) was below the epidemic threshold for the week ending March 11.

Laboratory Surveillance

During March 5-11, World Health Organization (WHO) collaborating laboratories and National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories in the United States reported testing 3,548 specimens for influenza viruses, of which 917 (25.8%) were positive. Of these, 223 were influenza A (H3N2) viruses, 43 were influenza A (H1N1) viruses, 430 were influenza A viruses that were not subtyped, and 221 were influenza B viruses.

Since October 2, 2005, WHO and NREVSS laboratories have tested 95,533 specimens for influenza viruses, of which 10,632 (11.1%) were positive. Of these, 9,693 (91.2%) were influenza A viruses, and 939 (8.8%) were influenza B viruses. Of the 9,693 influenza A viruses, 4,132 (42.6%) have been subtyped; 4,002 (96.9%) were influenza A (H3N2) viruses, and 130 (3.1%) were influenza A (H1N1) viruses.

P&I Mortality and ILI Surveillance

During the week ending March 11, P&I accounted for 7.6% of all deaths reported through the 122 Cities Mortality Reporting System. This percentage is below the epidemic threshold†† of 8.3% (Figure 2).

The percentage of patient visits for ILI was 3.0%, which is above the national baseline of 2.2% (Figure 3). The percentage of patient visits for ILI ranged from 1.7% in the Pacific region to 5.3% in the West South Central region.

Pediatric Deaths and Hospitalizations

During October 2, 2005--March 11, 2006, CDC received reports of 16 influenza-associated deaths in U.S. residents aged <18 years. Fourteen of the deaths occurred during the current influenza season, and two occurred during the 2004--05 influenza season.

During October 1, 2005--March 4, 2006, the preliminary laboratory-confirmed influenza-associated hospitalization rate reported by the Emerging Infections Program §§ (EIP) for children aged 0--17 years was 0.60 per 10,000. For children aged 0--4 years and 5--17 years, the rate was 1.44 per 10,000 and 0.19 per 10,000, respectively. During October 30, 2005--March 4, 2006, the preliminary laboratory-confirmed influenza-associated hospitalization rate for children aged 0--4 years in the New Vaccine Surveillance Network¶¶ (NVSN) was 2.1 per 10,000.

Human Avian Influenza A (H5N1)

No human avian influenza A (H5N1) virus infection has ever been identified in the United States. From December 2003 through March 21, 2006, a total of 184 laboratory-confirmed human avian influenza A (H5N1) infections were reported to WHO from Azerbaijan, Cambodia, China, Indonesia, Iraq, Thailand, Turkey, and Vietnam.*** Of these, 103 (56%) were fatal (Table). This represents an increase of seven cases and five deaths in Azerbaijan since March 13 and the first human infections with avian influenza A (H5N1) reported in Azerbaijan. The majority of infections appear to have been acquired from direct contact with infected poultry. No evidence of sustained human-to-human transmission of H5N1 has been detected, although rare instances of human-to-human transmission likely have occurred (1).


  1. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005; 352:333--40.

* Provisional data reported as of March 17. Additional information about influenza activity is updated each Friday and is available from CDC at

Levels of activity are 1) widespread: outbreaks of influenza or increases in influenza-like illness (ILI) cases and recent laboratory-confirmed influenza in at least half the regions of a state; 2) regional: outbreaks of influenza or increases in ILI cases and recent laboratory-confirmed influenza in at least two but less than half the regions of a state; 3) local: outbreaks of influenza or increases in ILI cases and recent laboratory-confirmed influenza in a single region of a state; 4) sporadic: small numbers of laboratory-confirmed influenza cases or a single influenza outbreak reported but no increase in cases of ILI; and 5) no activity.

§ Widespread: Alabama, Arkansas, Colorado, Connecticut, Delaware, Florida, Indiana, Iowa, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Montana, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Vermont, Virginia, and Wisconsin; regional: Colorado, Georgia, Hawaii, Illinois, Kansas, Maine, Michigan, Mississippi, Missouri, Nebraska, New Hampshire, New Jersey, North Dakota, Oklahoma, West Virginia, and Wyoming; local: California, Nevada, and Oregon; sporadic: Alaska, Arizona, Idaho, New Mexico, Utah, and Washington; no activity: none; no report: none.

Temperature of >100.0°F (>37.8°C) and cough and/or sore throat in the absence of a known cause other than influenza.

** The national baseline was calculated as the mean percentage of visits for ILI during noninfluenza weeks for the preceding three seasons, plus two standard deviations. Noninfluenza weeks are those in which <10% of laboratory specimens are positive for influenza. Wide variability in regional data precludes calculating region-specific baselines; therefore, applying the national baseline to regional data is inappropriate.

†† The expected seasonal baseline proportion of P&I deaths reported by the 122 Cities Mortality Reporting System is projected using a robust regression procedure in which a periodic regression model is applied to the observed percentage of deaths from P&I that occurred during the preceding 5 years. The epidemic threshold is 1.645 standard deviations above the seasonal baseline.

§§ The Emerging Infections Program Influenza Project conducts surveillance in 60 counties associated with 12 metropolitan areas: San Francisco, California; Denver, Colorado; New Haven, Connecticut; Atlanta, Georgia; Baltimore, Maryland; Minneapolis/St. Paul, Minnesota; Albuquerque, New Mexico; Las Cruces, New Mexico; Albany, New York; Rochester, New York; Portland, Oregon; and Nashville, Tennessee.

¶¶ The New Vaccine Surveillance Network conducts surveillance in Monroe County, New York; Hamilton County, Ohio; and Davidson County, Tennessee.

*** Available at

Figure 1

Figure 1
Return to top.
Figure 2

Figure 2
Return to top.
Figure 3

Figure 3
Return to top.

Table 4
Return to top.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to

Date last reviewed: 3/23/2006


Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A


Department of Health
and Human Services